Use of doxycycline to decrease the growth rate of abdominal aortic aneurysms: A randomized, double-blind, placebo-controlled pilot study

Journal of Vascular Surgery

Volumn 34, Issue 4, 2001, Pages 606-610

  Mosorin, Martti ^a   Juvonen, Jukka ^b   Biancari, Fausto ^a   Satta, Jari ^a   Surcel, Heljä Marja ^c   Leinonen, Maija ^c   Saikku, Pekka ^a,c   Juvonen, Tatu ^a,d  

^a UNIVERSITY OF OULU   (Finland)

^b KAINUU CENTRAL HOSPITAL   (Finland)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIUM ANTIBODY; C REACTIVE PROTEIN; DOXYCYCLINE; IMMUNOGLOBULIN G; MATRIX METALLOPROTEINASE;

ABDOMINAL AORTA ANEURYSM; AGED; ARTICLE; BACTERIAL INFECTION; BLOOD; CHLAMYDOPHILA PNEUMONIAE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DRUG ANTAGONISM; FEMALE; HUMAN; IMMUNOLOGY; INFLAMMATION; MALE; METABOLISM; MICROBIOLOGY; MIDDLE AGED; PATIENT SELECTION; PILOT STUDY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; TIME; TREATMENT OUTCOME;

AGED; ANTI-BACTERIAL AGENTS; ANTIBODIES, BACTERIAL; AORTIC ANEURYSM, ABDOMINAL; C-REACTIVE PROTEIN; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; DOXYCYCLINE; FEMALE; HUMANS; IMMUNOGLOBULIN G; INFLAMMATION; MALE; MATRIX METALLOPROTEINASES; MIDDLE AGED; PATIENT SELECTION; PILOT PROJECTS; PROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 0035488854     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1067/mva.2001.117891     Document Type: Article

References (28)

1. Nevitt MP, Ballard DJ, Hallett JW Jr. Prognosis of abdominal aortic aneurysms. A population-based study. N Engl J Med 1989;321:1009-14.
2. The UK Small Aneurysm Trial Participants. Mortality results for randomised controlled trial of early elective surgery or ultrasonographic surveillance for small abdominal aortic aneurysms. Lancet 1998;352:1649-55.
3. Lederle FA, Johnson GR, Wilson SE, Chute EP, Hye RJ, Makaroun MS, et al. The aneurysm detection and management study screening program. Validation cohort and final results. Arch Intern Med 2000;160:1425-30.
4. Satta J, Laurila A, Paakko P, Haukipuro K, Sormunen R, Parkkila S, et al. Chronic inflammation and elastin degradation in abdominal aortic aneurysm disease: an immunohistochemical and electron microscopic study. Eur J Vasc Endovasc Surg 1998;15:313-9.
5. Juvonen J, Juvonen T, Laurila A, Alakarppa H, Lounatmaa K, Surcel HM, et al. Demonstration of Chlamydia pneumoniae in the walls of abdominal aortic aneurysms. J Vasc Surg 1997;25:499-505.
6. Halme S, Juvonen T, Laurila A, Juvonen J, Mosorin M, Saikku P, et al. Chlamydia pneumoniae reactive T lymphocytes in the walls of abdominal aortic aneurysms. Eur J Clin Invest 1999;29:546-52.
7. Pyo R, Lee JK, Shipley JM, Curci JA, Mao D, Ziporin SJ, et al. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J Clin Invest 2000;105:1641-9.
8. Kol A, Suhkova GK, Lichtman AH, Libby P. Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression. Circulation 1998;28:300-7.
9. Curci JA, Petrinec D, Liao S, Golub LM, Thompson RW. Pharmacologic suppression of experimental abdominal aortic aneurysms: a comparison of doxycycline and four chemically modified tetracyclines. J Vasc Surg 1998;28:1082-93.
10. Curci JA, Mao D, Bohner DG, Allen BT, Rubin BG, Reilly JM, et al. Preoperative treatment with doxycycline reduces aortic wall expression and activation of matrix metalloproteinases in patients with abdominal aortic aneurysms. J Vasc Surg 2000;31:325-42.
11. Savola V, Penttilä T-L, Pettersson K, Lövgren T. Rapid, quantitative and highly sensitive determination of C-reactive protein (CRP) in whole blood. Scand J Clin Lab Invest 1998;58(Suppl 228):70.
12. Schermerhorn ML, Birkmeyer JD, Gould DA, Cronenwett JL. Cost-effectiveness of surgery for small abdominal aortic aneurysms on the basis of data from the United Kingdom Small Aneurysm Trial. J Vasc Surg 2000;31:217-26.
13. Gilling-Smith GL, Martin J, Sudhindran S, Gould DA, McWilliams RG, Bakran A, et al. Freedom from endoleak after endovascular aneurysm repair does not equal treatment success. Eur J Vasc Endovasc Surg 2000;19:421-5.
14. Resch T, Ivancev K, Brunkwall J, Nyman U, Malina M, Lindblad B. Distal migration of stent-grafts after endovascular repair of abdominal aortic aneurysms. J Vasc Interv Radiol 1999;10:257-66.
15. Wever JJ, de Nie AJ, Blankensteijn JD, Broeders IA, Mali WP, Eikelboom BC. Dilatation of the proximal neck of infrarenal aortic aneurysms after endovascular AAA repair. Eur J Vasc Endovasc Surg 2000;19:197-201.
16. MacSweeney STR, Ellis M, Worrell PC, Greenhalgh RM, Powell JT. Smoking and growth rate of small abdominal aortic aneurysms. Lancet 1994;344:651-2.
17. Strachan DP. Predictors of death from aortic aneurysm among middle-aged men: the Whitehall study. Br J Surg 1991;78:401-4.
18. Gadowski GR, Pilcher DB, Ricci MA. Abdominal aortic aneurysm expansion rate: effect of size and beta-adrenergic blockade. J Vasc Surg 1994;19:727-31.
19. Leach SD, Toole AL, Stern H, DeNatale RW, Tilson MD. Effect of β-adrenergic blockade on the growth rate of abdominal aortic aneurysms. Arch Surg 1988;123:606-9.
20. Lindholt JS, Henneberg EW, Juul S, Fasting H. Impaired results of a randomised double blinded clinical trial of propranolol versus placebo on the expansion rate of small abdominal aortic aneurysms. Int Angiol 1999;18:52-7.
21. Thompson RW, Baxter BT. MMP inhibition in abdominal aortic aneurysms. Rationale for a prospective randomized clinical trial. Ann N Y Acad Sci 1999;878:159-78.
22. Boyle JR, McDermott E, Crowther M, Wills AD, Bell PR, Thompson MM. Doxycycline inhibits elastin degradation and reduces metalloproteinases activity in a model of aneurysmal disease. J Vasc Surg 1998;27:354-61.
23. Blasi F, Denti F, Erba M, Cosentini R, Raccanelli R, Rinaldi A, et al. Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms. J Clin Microbiol 1996;34: 2766-9.
24. Petersen E, Boman J, Persson K, Arnerlov C, Wadell G, Juto P, et al. Chlamydia pneumoniae in human abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 1998;15:138-42.
25. Lindholt JS, Juul S, Vammen S, Lind I, Fasting H, Henneberg EW. Immunoglobulin A antibodies against Chlamydia pneumoniae are associated with expansion of abdominal aortic aneurysm. Br J Surg 1999;86:634-8.
26. Haverkate F, Thompson SG, Pyke SDM, Gallimore JR, Pepys MB. Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet 1997;349:462-6.
27. Anderson JL, Carlquist JF, Muhlestein JB, Horne BD, Elmer SP. Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction. J Am Coll Cardiol 1998;32:35-41.
28. Roivainen M, Viik-Kajander M, Palosuo T, Toivanen P, Leinonen M, Saikku P, et al. Infection, inflammation and the risk of coronary heart disease. Circulation 2000;101:252-7.